Dunja Vujic-Podlipec

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The aim of this study was to assess the pharmacodynamic equivalence of two different slow-release formulations of nifedipine (CAS-21829-25-4). In a prospective, controlled, double-blind clinical trial, 42 patients with essential hypertension (sitting diastolic blood pressure (DBP) 95-114 mmHg) underwent an initial washout, drug free period of 2 weeks, after(More)
  • 1